Recession odds climb on Wall Street as economy shows cracks beneath the surface
Federal Reserve Chair Jerome Powell last week pushed back when asked whether stagflation posed a threat to the…
Pfizer Lyme disease vaccine fails trial, company to seek FDA approval
Thomas Fuller | Nurphoto | Getty Images Pfizer on Monday said it will seek regulatory approval for a…
China Development Forum welcomes U.S. execs revamping market push
Apple CEO Tim Cook (L) stands with Siemens CEO Roland Busch prior to the opening ceremony of the…
Stopping GLP-1s raises cardiovascular risks: study
Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. Hollie Adams | Reuters…
Fourth-quarter GDP revised down to just 0.7% growth; January core inflation was 3.1%
Economic growth was much slower than expected in the final three months of 2025 while core inflation rose…
We’re dipping into our large cash pile to buy more of this health-care stock
We are buying 90 shares of Cardinal Health at roughly $217. Following the trade, Jim Cramer’s Charitable Trust…
Private companies added 63,000 jobs in February, January revised to just 11,000 additions, ADP says
Private sector hiring was a bit better than expected in February, though most of the job creation came…
We’re initiating a position in this health-care stock with a $260 price target
Shortly after the opening bell, we will initiate a position in Cardinal Health , buying 170 shares at…
We’re adding a stock to our Bullpen; resistant to recessions, AI disruption
We added a new Bullpen name during Friday’s Monthly Meeting, and it has minimal economic sensitivity and faces…
Hims & Hers Health to acquire Australia’s Eucalyptus for up to $1.15 billion
Hims & Hers Health said on Thursday it will acquire Australian digital health company Eucalyptus in a deal…